Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1593, Issue 1, 2002, Pages 93-98

  Matsuda, Hideyasu ^a   Kinoshita, Kayoko ^a   Sumida, Akihiko ^a   Takahashi, Koichi ^b   Fukuen, Shuichi ^a   Fukuda, Tsuyoshi ^a   Takahashi, Kyoko ^a   Yamamoto, Isamu ^a   Azuma, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

CYP mRNA; CYP3A4; HepG2 cell; Induction; RT competitive PCR; Taurine

Indexed keywords

CYTOCHROME P450 3A4; MESSENGER RNA; PHENOBARBITAL; RIFAMPICIN; TAURINE;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ENHANCER REGION; FOOD; HUMAN; HUMAN CELL; NUTRIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ARYL HYDROCARBON HYDROXYLASES; BETA-ALANINE; CELL LINE; CYTOCHROME P-450 CYP3A; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; OXIDOREDUCTASES, N-DEMETHYLATING; PHENOBARBITAL; RIFAMPIN; TAURINE; TIME FACTORS;

EID: 0037121532     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00345-2     Document Type: Article

References (35)

1. Chesney R.W. Taurine: its biological role and clinical implications. Adv. Pediatr. 32:1985;1-42.
2. Wright C.E. Taurine: biological update. Ann. Rev. Biochem. 55:1986;427-453.
3. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
4. Thurston J.H., Hauhart R.E., Dirgo J.A. Taurine: a role in osmotic regulation of mammalian brain and possible clinical significance. Life Sci. 26:1980;1561-1568.
5. Pasantes-Morales H., Wright C.E., Gaull G.E. Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem. Pharmacol. 34:1985;2205-2207.
6. Nakamura T., Ogasawara M., Koyama I., Nemoto M., Yoshida T. The protective effect of taurine on the biomembrane against damage produced by oxygen radicals. Biol. Pharm. Bull. 16:1993;970-972.
7. Kuriyama K. Taurine as a neuromodulator. Fed. Proc. 39:1980;2680-2684.
8. Bernardi N. On the role of taurine in the cerebellar cortex: a reappraisal. Acta Physiol. Pharmacol. Latinoam. 35:1985;153-164.
9. Sturman J.A. Nutritional taurine and central nervous system development. Ann. N.Y. Acad. Sci. 477:1986;196-213.
10. Azuma J., Hasegawa H., Awata N., Sawamura A., Harada H., Ogura K., Ohta H., Yamauchi K., Kishimoto S. Taurine for treatment of congestive heart failure in humans. Prog. Clin. Biol. Res. 125:1983;61-72.
11. Colombo C., Battezzati P.M., Crosignani A., Assaisso M., Ronchi M., Giunta A. Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis. Acta Univ. Carol. 36:1990;148-151.
12. Mochizuki H., Oda H., Yokogoshi H. Dietary taurine potentiates polychlorinated biphenyl-induced hypercholesterolemia in rats. J. Nutr. Biochem. 12:2001;109-115.
13. Marchesi G.F., Quattrini A., Scarpino O., Dellantonio R. Therapeutic effects of taurine in epilepsy: a clinical and polyphysiographic study. Riv. Patol. Nerv. Ment. 96:1975;166-184.
14. Chipponi J.X., Bleier J.C., Santi M.T., Rudman D. Deficiencies of essential and conditionally essential nutrients. Am. J. Clin. Nutr. 35:1982;1112-1116.
15. Sumida A., Fukuen S., Yamamoto I., Matsuda H., Naohara M., Azuma J. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochem. Biophys. Res. Commun. 267:2000;756-760.
16. Sumida A., Kinoshita K., Fukuda T., Matsuda H., Yamamoto I., Inaba T., Azuma J. Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver. Biochem. Biophys. Res. Commun. 262:1999;499-503.
17. Ha H.R., Chen J., Leuenberger P.M., Freiburghaus A.U., Follath F. In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur. J. Clin. Pharmacol. 48:1995;367-371.
18. Moore L.B., Goodwin B., Jones S.A., Wisely G.B., Serabjit-Singh C.J., Willson T.M., Collins J.L., Kliewer S.A. St. John's work induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7500-7502.
19. Kerai M.D., Waterfield C.J., Kenyon S.H., Asker D.S., Timbrell J.A. Reversal of ethanol-induces hepatic steatosis and lipid peroxidation by taurine: a study in rats. Alcohol Alcohol. 34:1999;529-541.
20. Labudova O., Yeghiazarjan C., Hoger H., Lubec G. Taurine modulates expression of transporters in rat brain and heart. Amino Acids. 17:1999;301-313.
21. Bitoun M., Tappaz M. Taurine down-regulates basal and osmolarity-induced gene expression of its transporter, but not the gene expression of its biosynthetic enzymes, in astrocyte primary cultures. J. Neurochem. 75:2000;919-924.
22. Moenkemann H., Labudova O., Yeghiazarian K., Rink H., Hoeger H., Lubec G. Evidence that taurine modulates osmoregulation by modification of osmolarity sensor protein ENVZ-expression. Amino Acids. 17:1999;347-355.
23. Kolars J.C., Schmiedlin-Ren P., Schuetz J.D., Fang C., Watkins P.B. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J. Clin. Invest. 90:1992;1871-1878.
24. Muntane-Relat J., Ourlin J.C., Domergue J., Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology. 22:1995;1143-1153.
25. Schuetz E.G., Schuetz J.D., Strom S.C., Thompson M.T., Fisher R.A., Molowa D.T., Li D., Guzelian P.S. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology. 18:1993;1254-1262.
26. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., Perlmann T., Lehmann J.M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:1998;73-82.
27. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102:1998;1016-1023.
28. Pascussi J.M., Drocourt L., Fabre J.M., Maurel P., Vilarem M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 58:2000;361-372.
29. Sueyoshi T., Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol. 41:2001;123-143.
30. Waxman D.J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369:1999;11-23.
31. Stieger B., Fattinger K., Madon J., Kullak-Ublick G.A., Meier P.J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 118:2000;422-430.
32. Hardison W.G., Proffitt J.H. Influence of hepatic taurine concentration on bile acid conjugation with taurine. Am. J. Physiol. 232:1977;E75-E79.
33. Hardison W.G. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology. 75:1978;71-75.
34. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., Liu Y., Klaassen C.D., Brown K.K., Reinhard J., Willson T.M., Koller B.H., Kliewer S.A. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3369-3374.
35. Xie W., Radominska-Pandya A., Shi Y., Simon C.M., Nelson M.C., Ong E.S., Waxman D.J., Evans R.M. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3375-3380.